Richard P. Polisson

2.6k total citations · 1 hit paper
30 papers, 1.7k citations indexed

About

Richard P. Polisson is a scholar working on Rheumatology, Immunology and Pharmacology. According to data from OpenAlex, Richard P. Polisson has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 7 papers in Immunology and 6 papers in Pharmacology. Recurrent topics in Richard P. Polisson's work include Rheumatoid Arthritis Research and Therapies (12 papers), Systemic Lupus Erythematosus Research (8 papers) and Inflammatory mediators and NSAID effects (5 papers). Richard P. Polisson is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Systemic Lupus Erythematosus Research (8 papers) and Inflammatory mediators and NSAID effects (5 papers). Richard P. Polisson collaborates with scholars based in United States, Australia and Canada. Richard P. Polisson's co-authors include Michael M. Ward, David S. Caldwell, John R. Rice, Nancy B. Allen, Peter A. Merkel, Michael E. Luggen, Stephen L. Dahl, Robert F. Willkens, John Ward and Cecil O. Samuelson and has published in prestigious journals such as New England Journal of Medicine, Blood and The American Journal of Medicine.

In The Last Decade

Richard P. Polisson

30 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial

1985 382 citations Richard P. Polisson et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard P. Polisson United States	19	1.0k	316	296	288	241	30	1.7k
Richard Brasington United States	22	868 0.8×	204 0.6×	195 0.7×	338 1.2×	191 0.8×	41	1.7k
John Sibley Canada	20	1.7k 1.6×	724 2.3×	357 1.2×	528 1.8×	305 1.3×	37	2.8k
R. Rau Germany	20	1.2k 1.2×	167 0.5×	440 1.5×	200 0.7×	162 0.7×	49	1.5k
Antonio Carletto Italy	22	797 0.8×	481 1.5×	253 0.9×	620 2.2×	207 0.9×	133	2.0k
Marc C. Hochberg United States	8	1.2k 1.2×	203 0.6×	146 0.5×	362 1.3×	573 2.4×	9	2.1k
F Mignon France	22	402 0.4×	205 0.6×	172 0.6×	289 1.0×	161 0.7×	70	1.9k
Leo B. A. Van De Putte Netherlands	18	1.4k 1.4×	164 0.5×	378 1.3×	615 2.1×	152 0.6×	34	2.6k
Irene E. M. Bultink Netherlands	29	1.5k 1.4×	297 0.9×	262 0.9×	576 2.0×	273 1.1×	75	2.5k
Levinus B. A. van de Putte Netherlands	21	1.0k 1.0×	121 0.4×	328 1.1×	267 0.9×	158 0.7×	37	1.4k
Tamer A. Gheita Egypt	27	1.0k 1.0×	262 0.8×	266 0.9×	572 2.0×	182 0.8×	109	2.0k

Countries citing papers authored by Richard P. Polisson

Since Specialization

Citations

This map shows the geographic impact of Richard P. Polisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard P. Polisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard P. Polisson more than expected).

Fields of papers citing papers by Richard P. Polisson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard P. Polisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard P. Polisson. The network helps show where Richard P. Polisson may publish in the future.

Co-authorship network of co-authors of Richard P. Polisson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard P. Polisson. A scholar is included among the top collaborators of Richard P. Polisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard P. Polisson. Richard P. Polisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Warren, Julia T., Kelly Walkovich, Audrey Anna Bolyard, et al.. (2022). Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study. Blood. 140(Supplement 1). 1408–1410. 2 indexed citations

Merkel, Peter A., Nancy Silliman, Christopher P. Denton, et al.. (2008). Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial. Arthritis Care & Research. 59(5). 699–705. 80 indexed citations

Furst, Daniel E., Dinesh Khanna, Marco Matucci‐Cerinic, et al.. (2007). Systemic sclerosis - continuing progress in developing clinical measures of response.. PubMed. 34(5). 1194–200. 64 indexed citations

Bellamy, Nicholas, Mary Bell, Dan Pericak, et al.. (2006). BLISS index for analyzing knee osteoarthritis trials data. Journal of Clinical Epidemiology. 60(2). 124–132. 20 indexed citations

Polisson, Richard P., et al.. (2005). Case 29-2005. New England Journal of Medicine. 353(12). 1275–1284. 4 indexed citations

Bellamy, Nicholas, Mary Bell, Charlie H. Goldsmith, et al.. (2005). The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT–OARSI. Osteoarthritis and Cartilage. 13(2). 104–110. 25 indexed citations

Fürst, Daniel E., Michael H. Weisman, Harold E. Paulus, et al.. (2003). Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.. PubMed. 30(10). 2123–6. 8 indexed citations

Polisson, Richard P.. (2001). Innovative therapies in osteoarthritis. Current Rheumatology Reports. 3(6). 489–495. 10 indexed citations

Polisson, Richard P., et al.. (1997). NSAIDs and the Elderly. Drugs & Aging. 10(2). 119–130. 37 indexed citations

10.

Polisson, Richard P.. (1996). Nonsteroidal anti-inflammatory drugs: Practical and theoretical considerations in their selection. The American Journal of Medicine. 100(2). 31S–36S. 79 indexed citations

11.

Merkel, Peter A., et al.. (1996). The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. The American Journal of Medicine. 101(6). 576–583. 109 indexed citations

12.

Polisson, Richard P., Alan J. Fischman, Robert H. Rubin, et al.. (1995). Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis & Rheumatism. 38(6). 819–825. 103 indexed citations

13.

Polisson, Richard P., Mary Anne Dooley, Deborah V. Dawson, & David S. Pisetsky. (1994). Interleukin‐2 Receptor Levels in the Sera of Rheumatoid Arthritis Patients Treated with Methotrexate. Arthritis & Rheumatism. 37(1). 50–56. 13 indexed citations

14.

Weinblatt, Michael E., Richard P. Polisson, Steven Blotner, et al.. (1993). The effects of drug therapy on radiographic progression of rheumatoid arthritis. results of a 36‐week randomized trial comparing methotrexate and auranofin. Arthritis & Rheumatism. 36(5). 613–619. 74 indexed citations

15.

Martinez, Salutario, et al.. (1990). Iliopsoas bursitis: Clinical features, radiographic findings, and disease associations. Seminars in Arthritis and Rheumatism. 20(1). 41–47. 38 indexed citations

16.

Weinblatt, Michael E., Herbert Kaplan, Bernard F. Germain, et al.. (1990). Low‐dose methotrexate compared with auranofin in adult rheumatoid arthritis. Arthritis & Rheumatism. 33(3). 330–338. 97 indexed citations

17.

Clair, E. William St., Charles C. Query, Rex C. Bentley, et al.. (1990). Expression of autoantibodies to recombinant (U1) RNP-associated 70K antigen in systemic lupus erythematosus. Clinical Immunology and Immunopathology. 54(2). 266–280. 18 indexed citations

18.

Ward, Michael M. & Richard P. Polisson. (1989). A meta‐analysis of the clinical manifestations of older‐onset systemic lupus erythematosus. Arthritis & Rheumatism. 32(10). 1226–1232. 86 indexed citations

19.

Shergy, William, Richard P. Polisson, David S. Caldwell, et al.. (1988). Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis. The American Journal of Medicine. 85(6). 771–774. 80 indexed citations

20.

Studenski, Stephanie, David S. Caldwell, Nancy B. Allen, John R. Rice, & Richard P. Polisson. (1987). Survival in systemic lupus erythematosus. a multivariate analysis of demographic factors. Arthritis & Rheumatism. 30(12). 1326–1332. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact